Safety Study of Tivanisiran to Treat Dry Eye | MicrobiomeTrials← Back to trialsNCT05310422
Safety Study of Tivanisiran to Treat Dry Eye
CompletedPHASE3INTERVENTIONAL
Trial Details
Start: 2022-03-24Est. Completion: 2023-10-11
Enrollment target: 301 participants Locations- Sylentis Investigative Site, Chandler, Arizona, United States
- Sylentis Investigative Site, Phoenix, Arizona, United States
- FYDES Investigative Site, Glendale, California, United States
- Sylentis Investigative Site, Hemet, California, United States
- Sylentis Investigative Site, Los Angeles, California, United States
- Sylentis Investigative Site, Murrieta, California, United States
- Sylentis Investigative Site, Newport Beach, California, United States
- FYDES Investigative Site, Delray Beach, Florida, United States
- FYDES Investigative Site, Jacksonville, Florida, United States
- Sylentis Investigative Site, Largo, Florida, United States
- Sylentis Investigative Site, Morrow, Georgia, United States
- Sylentis Investigative Site, Fraser, Michigan, United States
- Sylentis Investigative Site, Kansas City, Missouri, United States
- FYDES Investigative Site, St Louis, Missouri, United States
- Sylentis Investigative Site, Washington, Missouri, United States
- Sylentis Investigative Site, Rochester, New York, United States
- Sylentis Investigative Site, Asheville, North Carolina, United States
- Sylentis Investigative Site, Garner, North Carolina, United States
- Sylentis Investigative Site, Cranberry Township, Pennsylvania, United States
- Sylentis Investigative Site, Rapid City, South Dakota, United States
- Sylentis Investigative Site, Memphis, Tennessee, United States
- Sylentis Investigative Site, Austin, Texas, United States
- FYDES Investigative Site, El Paso, Texas, United States
- Sylentis Investigative Site, San Antonio, Texas, United States
- Sylentis Investigative Site, San Antonio, Texas, United States
Other microbiome trials you might be interested in
Dry Eye Disease (DED)
The purpose of this study is to evaluate the short-term effects (impact on tear film and dry eye symptoms) of the BriTer…
Rochester, United StatesEst. completion Jul 1, 2027
Eye DiseasesMacular Degeneration, WetSub-Macular Hemorrhage
The centre of the retina (macula) at the back of the eye contains cells that give us our central vision that we use for …
Bonn, GermanyEst. completion Dec 2028
Phase 1
SUSPENDED
Hematopoietic and Lymphatic System Neoplasm
This phase I trial studies how well biomarker-guided ruxolitinib works for the prevention of chronic graft versus host d…
Duarte, United StatesCompleted Jun 22, 2028